EUCAST News

02.11.2023

bioMerieux has still not withdrawn the malfunctioning colistin AST material

This is a general and iterated EUCAST warning against material sold by bioMerieux for susceptibility testing (AST) of colistin. It is years since it was conclusively shown by scientists that material for AST sold by bioMerieux completely fails to meet acceptable accuracy, and the material is still sold by bioMerieux. The warning published several years ago has again been updated! The message is the same!

<- Back to: EUCAST News